Christopher Jakubowski, MD The Johns Hopkins discusses an abstract from The Journal of Clinical Oncology entitled Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma
Christopher Jakubowski, MD @HopkinsMedicine #ASCO20 Response to Crizotinib in ROS1 Fusion–Positive Intrahepatic Cholangiocarcinoma
By Editor